Type |
Details |
Score |
Interaction Experiment |
Description: |
Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Cbl-b mediates TGF sensitivity by downregulating inhibitory SMAD7 in primary T cells. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. |
|
•
•
•
•
•
|
Allele |
Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 4, Thomas Braun |
Allele Type: |
Targeted |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
426
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Kitamura K |
Year: |
2000 |
Journal: |
Blood |
Title: |
Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation. |
Volume: |
95 |
Issue: |
11 |
Pages: |
3371-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ferrigno O |
Year: |
2002 |
Journal: |
Oncogene |
Title: |
Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling. |
Volume: |
21 |
Issue: |
32 |
Pages: |
4879-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fukasawa H |
Year: |
2004 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. |
Volume: |
101 |
Issue: |
23 |
Pages: |
8687-92 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kamiya Y |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction. |
Volume: |
285 |
Issue: |
40 |
Pages: |
30804-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gruber T |
Year: |
2013 |
Journal: |
J Mol Cell Biol |
Title: |
Cbl-b mediates TGFβ sensitivity by downregulating inhibitory SMAD7 in primary T cells. |
Volume: |
5 |
Issue: |
6 |
Pages: |
358-68 |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
425
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Souchelnytskyi S |
Year: |
1998 |
Journal: |
J Biol Chem |
Title: |
Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors. |
Volume: |
273 |
Issue: |
39 |
Pages: |
25364-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hong S |
Year: |
2007 |
Journal: |
Nat Immunol |
Title: |
Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. |
Volume: |
8 |
Issue: |
5 |
Pages: |
504-13 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 1, Simon J Conway |
Allele Type: |
Transgenic |
Attribute String: |
Recombinase |
|
•
•
•
•
•
|
Allele |
Name: |
Regulatory region 54; endonuclease-mediated mutation 1, Axel Visel |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Modified regulatory region |
|
•
•
•
•
•
|
Publication |
First Author: |
Pulaski L |
Year: |
2001 |
Journal: |
J Biol Chem |
Title: |
Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation. |
Volume: |
276 |
Issue: |
17 |
Pages: |
14344-9 |
|
•
•
•
•
•
|
Allele |
Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 5.1, Mark A Magnussen |
Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
Allele |
Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 6.1, Mark A Magnussen |
Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, endonuclease-mediated mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rr54/Rr54 |
Background: |
FVB-Rr54 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang L |
Year: |
2021 |
Journal: |
Circulation |
Title: |
BMP9 and BMP10 Act Directly on Vascular Smooth Muscle Cells for Generation and Maintenance of the Contractile State. |
Volume: |
143 |
Issue: |
14 |
Pages: |
1394-1410 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Smad7-cre)1Sjc/? |
Background: |
involves: 129S/Sv * C3HeB/FeJ |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE40510 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Smad7-cre)1Sjc/? |
Background: |
involves: 129S4/SvJaeSor * C3HeB/FeJ |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Smad7-cre)1Sjc/? |
Background: |
involves: 129S/Sv * 129S4/SvJaeSor * C3HeB/FeJ |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Bai Y |
Year: |
2004 |
Journal: |
Mol Cell |
Title: |
Itch E3 ligase-mediated regulation of TGF-beta signaling by modulating smad2 phosphorylation. |
Volume: |
15 |
Issue: |
5 |
Pages: |
825-31 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor Tg(Smad7-cre)1Sjc/? |
Background: |
involves: 129S/Sv * 129S4/SvJaeSor * C3HeB/FeJ |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee YS |
Year: |
2008 |
Journal: |
Biochem Biophys Res Commun |
Title: |
AIMP1/p43 downregulates TGF-beta signaling via stabilization of smurf2. |
Volume: |
371 |
Issue: |
3 |
Pages: |
395-400 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vijayachandra K |
Year: |
2009 |
Journal: |
Mol Carcinog |
Title: |
Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes. |
Volume: |
48 |
Issue: |
3 |
Pages: |
181-186 |
|
•
•
•
•
•
|
Publication |
First Author: |
Halder LD |
Year: |
2020 |
Journal: |
Nat Commun |
Title: |
Immune modulation by complement receptor 3-dependent human monocyte TGF-β1-transporting vesicles. |
Volume: |
11 |
Issue: |
1 |
Pages: |
2331 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li M |
Year: |
2020 |
Journal: |
Elife |
Title: |
GAS5 protects against osteoporosis by targeting UPF1/SMAD7 axis in osteoblast differentiation. |
Volume: |
9 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Dominitzki S |
Year: |
2007 |
Journal: |
J Immunol |
Title: |
Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells. |
Volume: |
179 |
Issue: |
4 |
Pages: |
2041-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schlereth K |
Year: |
2018 |
Journal: |
Elife |
Title: |
The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium. |
Volume: |
7 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Hohenstein P |
Year: |
2003 |
Journal: |
Genes Chromosomes Cancer |
Title: |
Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene. |
Volume: |
36 |
Issue: |
3 |
Pages: |
273-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhong X |
Year: |
2013 |
Journal: |
Diabetologia |
Title: |
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. |
Volume: |
56 |
Issue: |
3 |
Pages: |
663-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dong L |
Year: |
2021 |
Journal: |
J Cell Mol Med |
Title: |
Deletion of Smad3 protects against diabetic myocardiopathy in db/db mice. |
Volume: |
25 |
Issue: |
10 |
Pages: |
4860-4869 |
|
•
•
•
•
•
|
Publication |
First Author: |
Reardon C |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death. |
Volume: |
180 |
Issue: |
12 |
Pages: |
8316-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ito Y |
Year: |
2002 |
Journal: |
Dev Dyn |
Title: |
Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor beta-mediated Meckel's cartilage development. |
Volume: |
224 |
Issue: |
1 |
Pages: |
69-78 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cho C |
Year: |
2020 |
Journal: |
Oncogene |
Title: |
Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis. |
Volume: |
39 |
Issue: |
38 |
Pages: |
6129-6137 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang X |
Year: |
2018 |
Journal: |
Arterioscler Thromb Vasc Biol |
Title: |
MicroRNA-21 Knockout Exacerbates Angiotensin II-Induced Thoracic Aortic Aneurysm and Dissection in Mice With Abnormal Transforming Growth Factor-β-SMAD3 Signaling. |
Volume: |
38 |
Issue: |
5 |
Pages: |
1086-1101 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu Z |
Year: |
2012 |
Journal: |
Am J Physiol Renal Physiol |
Title: |
Smad3 mediates ANG II-induced hypertensive kidney disease in mice. |
Volume: |
302 |
Issue: |
8 |
Pages: |
F986-97 |
|
•
•
•
•
•
|
Publication |
First Author: |
El-Gohary Y |
Year: |
2014 |
Journal: |
Diabetes |
Title: |
A smad signaling network regulates islet cell proliferation. |
Volume: |
63 |
Issue: |
1 |
Pages: |
224-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang XY |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Induction of thoracic aortic remodeling by endothelial-specific deletion of microRNA-21 in mice. |
Volume: |
8 |
Issue: |
3 |
Pages: |
e59002 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu J |
Year: |
2016 |
Journal: |
Oncogene |
Title: |
Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells. |
Volume: |
35 |
Issue: |
42 |
Pages: |
5468-5479 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sakata-Goto T |
Year: |
2012 |
Journal: |
Bone |
Title: |
Id2 controls chondrogenesis acting downstream of BMP signaling during maxillary morphogenesis. |
Volume: |
50 |
Issue: |
1 |
Pages: |
69-78 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pallangyo CK |
Year: |
2015 |
Journal: |
J Exp Med |
Title: |
IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis. |
Volume: |
212 |
Issue: |
13 |
Pages: |
2253-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Y |
Year: |
2024 |
Journal: |
FASEB J |
Title: |
Vascular smooth muscle cell-specific miRNA-214 deficiency alleviates simulated microgravity-induced vascular remodeling. |
Volume: |
38 |
Issue: |
1 |
Pages: |
e23369 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xylourgidis N |
Year: |
2019 |
Journal: |
Am J Physiol Lung Cell Mol Physiol |
Title: |
Role of dual-specificity protein phosphatase DUSP10/MKP-5 in pulmonary fibrosis. |
Volume: |
317 |
Issue: |
5 |
Pages: |
L678-L689 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ishida Y |
Year: |
2006 |
Journal: |
J Immunol |
Title: |
Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway. |
Volume: |
176 |
Issue: |
9 |
Pages: |
5598-606 |
|
•
•
•
•
•
|
Publication |
First Author: |
Giroux M |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
T cell activation leads to protein kinase C theta-dependent inhibition of TGF-beta signaling. |
Volume: |
185 |
Issue: |
3 |
Pages: |
1568-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tang YJ |
Year: |
2014 |
Journal: |
Am J Respir Cell Mol Biol |
Title: |
Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice. |
Volume: |
51 |
Issue: |
6 |
Pages: |
761-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang XR |
Year: |
2008 |
Journal: |
J Am Soc Nephrol |
Title: |
Latent TGF-beta1 protects against crescentic glomerulonephritis. |
Volume: |
19 |
Issue: |
2 |
Pages: |
233-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gai Z |
Year: |
2010 |
Journal: |
J Am Soc Nephrol |
Title: |
Trps1 haploinsufficiency promotes renal fibrosis by increasing Arkadia expression. |
Volume: |
21 |
Issue: |
9 |
Pages: |
1468-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stavropoulos A |
Year: |
2022 |
Journal: |
Sci Signal |
Title: |
Coordinated activation of TGF-β and BMP pathways promotes autophagy and limits liver injury after acetaminophen intoxication. |
Volume: |
15 |
Issue: |
740 |
Pages: |
eabn4395 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gencer S |
Year: |
2017 |
Journal: |
Sci Signal |
Title: |
TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis. |
Volume: |
10 |
Issue: |
502 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Sun Q |
Year: |
2018 |
Journal: |
J Cell Sci |
Title: |
The feedback loop between miR-21, PDCD4 and AP-1 functions as a driving force for renal fibrogenesis. |
Volume: |
131 |
Issue: |
6 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Almahariq M |
Year: |
2015 |
Journal: |
Biochem J |
Title: |
Exchange protein directly activated by cAMP modulates regulatory T-cell-mediated immunosuppression. |
Volume: |
465 |
Issue: |
2 |
Pages: |
295-303 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang Y |
Year: |
2020 |
Journal: |
FASEB J |
Title: |
8-Oxoguanine DNA glycosylase modulates the cell transformation process in pulmonary fibrosis by inhibiting Smad2/3 and interacting with Smad7. |
Volume: |
34 |
Issue: |
10 |
Pages: |
13461-13473 |
|
•
•
•
•
•
|
Publication |
First Author: |
Seitz R |
Year: |
2018 |
Journal: |
Invest Ophthalmol Vis Sci |
Title: |
Cross-Inhibition of Norrin and TGF-β Signaling Modulates Development of Retinal and Choroidal Vasculature. |
Volume: |
59 |
Issue: |
6 |
Pages: |
2240-2251 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu RS |
Year: |
2017 |
Journal: |
Oncotarget |
Title: |
OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis. |
Volume: |
8 |
Issue: |
24 |
Pages: |
39401-39416 |
|
•
•
•
•
•
|
Publication |
First Author: |
He W |
Year: |
2001 |
Journal: |
Oncogene |
Title: |
Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis. |
Volume: |
20 |
Issue: |
4 |
Pages: |
471-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guda K |
Year: |
2001 |
Journal: |
Mol Carcinog |
Title: |
Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors. |
Volume: |
31 |
Issue: |
4 |
Pages: |
204-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yanagi Y |
Year: |
1999 |
Journal: |
J Biol Chem |
Title: |
Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. |
Volume: |
274 |
Issue: |
19 |
Pages: |
12971-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yu Z |
Year: |
2006 |
Journal: |
Biochem Biophys Res Commun |
Title: |
All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling. |
Volume: |
340 |
Issue: |
3 |
Pages: |
929-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saika S |
Year: |
2006 |
Journal: |
Am J Pathol |
Title: |
Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing. |
Volume: |
168 |
Issue: |
6 |
Pages: |
1848-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jeon SH |
Year: |
2007 |
Journal: |
J Leukoc Biol |
Title: |
Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. |
Volume: |
81 |
Issue: |
2 |
Pages: |
557-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chang X |
Year: |
2007 |
Journal: |
Mol Cell Biol |
Title: |
Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. |
Volume: |
27 |
Issue: |
17 |
Pages: |
6127-39 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim HA |
Year: |
2008 |
Journal: |
J Leukoc Biol |
Title: |
TGF-beta1 and IFN-gamma stimulate mouse macrophages to express BAFF via different signaling pathways. |
Volume: |
83 |
Issue: |
6 |
Pages: |
1431-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Singh R |
Year: |
2009 |
Journal: |
Endocrinology |
Title: |
Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways. |
Volume: |
150 |
Issue: |
3 |
Pages: |
1259-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Seong HA |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
Murine protein serine/threonine kinase 38 stimulates TGF-beta signaling in a kinase-dependent manner via direct phosphorylation of Smad proteins. |
Volume: |
285 |
Issue: |
40 |
Pages: |
30959-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ortiz C |
Year: |
2012 |
Journal: |
J Biol Chem |
Title: |
Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-β (TGF-β)-induced suppressor effects in hepatocytes. |
Volume: |
287 |
Issue: |
19 |
Pages: |
15263-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Taylor-Weiner H |
Year: |
2015 |
Journal: |
J Cell Sci |
Title: |
Traction forces mediated by integrin signaling are necessary for definitive endoderm specification. |
Volume: |
128 |
Issue: |
10 |
Pages: |
1961-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li X |
Year: |
2017 |
Journal: |
Biochem Biophys Res Commun |
Title: |
MicroRNA-21 promotes osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1/5/8-Runx2 pathway. |
Volume: |
493 |
Issue: |
2 |
Pages: |
928-933 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang R |
Year: |
2018 |
Journal: |
FASEB J |
Title: |
Identification of a TGF-β-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells. |
Volume: |
32 |
Issue: |
7 |
Pages: |
3936-3945 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu X |
Year: |
2019 |
Journal: |
Biochem Biophys Res Commun |
Title: |
IFNγ inhibits fibroblast-leading tumor cell invasion through downregulating N-cadherin. |
Volume: |
512 |
Issue: |
3 |
Pages: |
544-551 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bos JM |
Year: |
2012 |
Journal: |
J Cell Biochem |
Title: |
TGFβ-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy. |
Volume: |
113 |
Issue: |
6 |
Pages: |
1896-903 |
|
•
•
•
•
•
|
Publication |
First Author: |
Igalouzene R |
Year: |
2022 |
Journal: |
J Clin Invest |
Title: |
SMAD4 TGF-β-independent function preconditions naive CD8+ T cells to prevent severe chronic intestinal inflammation. |
Volume: |
132 |
Issue: |
8 |
|
|
•
•
•
•
•
|
Protein Domain |
Type: |
Homologous_superfamily |
Description: |
Smad proteins are signal transducers and transcriptional comodulators of the TGF-beta superfamily of ligands, which play a central role in regulating a broad range of cellular responses, including cell growth, differentiation, and specification of developmental fate, in diverse organisms from Caenorhabditis elegans to humans. Ligand binding to specific transmembrane receptor kinases induces receptor oligomerisation and phosphorylation of the receptor specific Smad protein (R-Smad) in the cytoplasm. The R-Smad proteins regulate distinct signalling pathways. Smad1, 5 and 8 mediate the signals of bone morphogenetic proteins (BMPs), while Smad2 and 3 mediate the signals of activins and TGF-betas. Upon ligand stimulation, R-Smad proteins are phosphorylated at the conserved C-terminal tail sequence, SS*xS* (where S* denotes a site of phosphorylation). The phosphorylated states of R-Smad proteins form heteromeric complexes with Smad4 and are translocated into the nucleus. In the nucleus, the heteromeric complexes function as gene-specific transcription activators by binding to promoters and interacting with transcriptional coactivators. Smad6 and Smad7 are inhibitory Smad proteins that inhibit TGF-beta signalling by interfering with either receptor-mediated phosphorylation or hetero-oligomerisation between Smad4 and R-Smad proteins. Smad proteins comprise two conserved MAD homology domains, one in the N terminus (MH1) and one in the C terminus (MH2), separated by a more variable, proline-rich linker region. The MH1 domain has a role in DNA binding and negatively regulates the functions of MH2 domain, whereas the MH2 domain is responsible for transactivation and mediates phosphorylation-triggered heteromeric assembly between Smad4 and R-Smad [, ]. The MH1 domain adopts a compact globular fold, with four alpha helices, six short beta strands, and five loops. The N-terminal half of the sequence consists of three alpha helices, and the C-terminal half contains all six beta strands, which form two small beta sheets and one beta hairpin. The fourth alpha helix is located in the hydrophobic core of the molecule, surrounded by the N-terminal three alpha helices on one side and by the two small beta sheets and the beta hairpin on the other side. These secondary structural elements are connected with five intervening surface loops. The MH1 domain employs a novel DNA-binding motif, an 11-residue β-hairpin formed by strands B2 and B3, to contact DNA in the major groove. Two residues in the L3 loop and immediately preceding strand B2 also contribute significantly to DNA recognition. The beta hairpin appears to protrude outward from the globular MH1 core []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Smad proteins are signal transducers and transcriptional comodulators of the TGF-beta superfamily of ligands, which play a central role in regulating a broad range of cellular responses, including cell growth, differentiation, and specification of developmental fate, in diverse organisms from Caenorhabditis elegans to humans. Ligand binding to specific transmembrane receptor kinases induces receptor oligomerisation and phosphorylation of the receptor specific Smad protein (R-Smad) in the cytoplasm. The R-Smad proteins regulate distinct signalling pathways. Smad1, 5 and 8 mediate the signals of bone morphogenetic proteins (BMPs), while Smad2 and 3 mediate the signals of activins and TGF-betas. Upon ligand stimulation, R-Smad proteins are phosphorylated at the conserved C-terminal tail sequence, SS*xS* (where S* denotes a site of phosphorylation). The phosphorylated states of R-Smad proteins form heteromeric complexes with Smad4 and are translocated into the nucleus. In the nucleus, the heteromeric complexes function as gene-specific transcription activators by binding to promoters and interacting with transcriptional coactivators. Smad6 and Smad7 are inhibitory Smad proteins that inhibit TGF-beta signalling by interfering with either receptor-mediated phosphorylation or hetero-oligomerisation between Smad4 and R-Smad proteins. Smad proteins comprise two conserved MAD homology domains, one in the N terminus (MH1) and one in the C terminus (MH2), separated by a more variable, proline-rich linker region. The MH1 domain has a role in DNA binding and negatively regulates the functions of MH2 domain, whereas the MH2 domain is responsible for transactivation and mediates phosphorylation-triggered heteromeric assembly between Smad4 and R-Smad [, ]. The MH1 domain adopts a compact globular fold, with four alpha helices, six short beta strands, and five loops. The N-terminal half of the sequence consists of three alpha helices, and the C-terminal half contains all six beta strands, which form two small beta sheets and one beta hairpin. The fourth alpha helix is located in the hydrophobic core of the molecule, surrounded by the N-terminal three alpha helices on one side and by the two small beta sheets and the beta hairpin on the other side. These secondary structural elements are connected with five intervening surface loops. The MH1 domain employs a novel DNA-binding motif, an 11-residue β-hairpin formed by strands B2 and B3, to contact DNA in the major groove. Two residues in the L3 loop and immediately preceding strand B2 also contribute significantly to DNA recognition. The beta hairpin appears to protrude outward from the globular MH1 core []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Shi Y |
Year: |
1998 |
Journal: |
Cell |
Title: |
Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. |
Volume: |
94 |
Issue: |
5 |
Pages: |
585-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Iezaki T |
Year: |
2016 |
Journal: |
J Bone Miner Res |
Title: |
The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption. |
Volume: |
31 |
Issue: |
3 |
Pages: |
573-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chung JY |
Year: |
2022 |
Journal: |
Int J Biol Sci |
Title: |
AANG Prevents Smad3-dependent Diabetic Nephropathy by Restoring Pancreatic β-Cell Development in db/db Mice. |
Volume: |
18 |
Issue: |
14 |
Pages: |
5489-5502 |
|
•
•
•
•
•
|
Publication |
First Author: |
Latella G |
Year: |
2009 |
Journal: |
Eur J Clin Invest |
Title: |
Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis. |
Volume: |
39 |
Issue: |
2 |
Pages: |
145-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Latella G |
Year: |
2009 |
Journal: |
Liver Int |
Title: |
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. |
Volume: |
29 |
Issue: |
7 |
Pages: |
997-1009 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Y |
Year: |
2021 |
Journal: |
FASEB J |
Title: |
Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7. |
Volume: |
35 |
Issue: |
11 |
Pages: |
e21947 |
|
•
•
•
•
•
|
Publication |
First Author: |
Su BH |
Year: |
2016 |
Journal: |
J Pathol |
Title: |
Over-expression of prothymosin-α antagonizes TGFβ signalling to promote the development of emphysema. |
Volume: |
238 |
Issue: |
3 |
Pages: |
412-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shen R |
Year: |
2006 |
Journal: |
J Biol Chem |
Title: |
Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. |
Volume: |
281 |
Issue: |
6 |
Pages: |
3569-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gu W |
Year: |
2015 |
Journal: |
PLoS Biol |
Title: |
A novel TGFβ modulator that uncouples R-Smad/I-Smad-mediated negative feedback from R-Smad/ligand-driven positive feedback. |
Volume: |
13 |
Issue: |
2 |
Pages: |
e1002051 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamamoto N |
Year: |
2016 |
Journal: |
Mol Cell Endocrinol |
Title: |
Heat shock protein 22 (HSPB8) limits TGF-β-stimulated migration of osteoblasts. |
Volume: |
436 |
|
Pages: |
1-9 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
244
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
235
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
179
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
143
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
209
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
194
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
204
 |
Fragment?: |
true |
|
•
•
•
•
•
|